Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.94% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Financials | 0.79% |
| 5 | Healthcare | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$94.8M
| $3.26M | ﹤0.01% |
+220,253
| New | +$3.04M |
|
4802
PUT
Dime Commercial Bancshares
DCOM
$1.79B
| $3.26M | ﹤0.01% |
121,000
+43,600
| +56% | +$1.14M |
|
4803
A2Z Smart Technologies
AZ
$280M
| $3.26M | ﹤0.01% |
+308,290
| New | +$2.64M |
|
4804
Cushman & Wakefield Ltd
CWK
$3.31B
| $3.26M | ﹤0.01% |
294,360
-28,679
| -9% | -$281K |
|
4805
iShares US Healthcare Providers ETF
IHF
$1.23B
| $3.25M | ﹤0.01% |
66,905
-13,722
| -17% | -$676K |
|
4806
Zymeworks
ZYME
$2.02B
| $3.25M | ﹤0.01% |
259,137
-92,024
| -26% | -$1.1M |
|
4807
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.44B
| $3.25M | ﹤0.01% |
+86,428
| New | +$3.1M |
|
4808
Genpact
G
$6.39B
| $3.25M | ﹤0.01% |
73,821
-5,289
| -7% | -$240K |
|
4809
CALL
Arqit Quantum
ARQQ
$349M
| $3.25M | ﹤0.01% |
87,700
+22,300
| +34% | +$478K |
|
|
FYBR
4810
PUT
DELISTED
Frontier Communications
FYBR
| $3.25M | ﹤0.01% |
89,200
+36,000
| +68% | +$1.31M |
|
4811
Banco Bilbao Vizcaya Argentaria
BBVA
$160B
| $3.25M | ﹤0.01% |
211,186
+21,883
| +12% | +$315K |
|
4812
iShares MSCI Kokusai Fund
TOK
$256M
| $3.25M | ﹤0.01% |
25,765
+515
| +2% | +$60.4K |
|
4813
PUT
State Street SPDR S&P Dividend ETF
SDY
$22B
| $3.24M | ﹤0.01% |
23,900
-6,400
| -21% | -$849K |
|
4814
CALL
Roivant Sciences
ROIV
$25.1B
| $3.24M | ﹤0.01% |
287,800
+63,500
| +28% | +$688K |
|
4815
CALL
Thor Industries
THO
$4.01B
| $3.24M | ﹤0.01% |
36,500
-32,400
| -47% | -$2.56M |
|
|
ETNB
4816
DELISTED
89bio
ETNB
| $3.24M | ﹤0.01% |
329,861
+161,751
| +96% | +$1.34M |
|
4817
PUT
Viridian Therapeutics
VRDN
$2.61B
| $3.24M | ﹤0.01% |
231,700
+221,600
| +2,194% | +$3.01M |
|
|
SRDX
4818
DELISTED
Surmodics
SRDX
| $3.24M | ﹤0.01% |
109,025
+87,287
| +402% | +$2.52M |
|
4819
PUT
iShares US Medical Devices ETF
IHI
$3.41B
| $3.24M | ﹤0.01% |
51,700
+34,900
| +208% | +$2.1M |
|
4820
AAR Corp
AIR
$5.36B
| $3.24M | ﹤0.01% |
47,074
+1,553
| +3% | +$93.2K |
|
4821
CALL
Imperial Oil
IMO
$63.1B
| $3.23M | ﹤0.01% |
40,700
+21,400
| +111% | +$1.53M |
|
4822
PUT
MakeMyTrip
MMYT
$5.55B
| $3.23M | ﹤0.01% |
33,000
+19,600
| +146% | +$1.98M |
|
4823
CALL
Badger Meter
BMI
$3.93B
| $3.23M | ﹤0.01% |
13,200
+5,300
| +67% | +$1.2M |
|
|
DFAI
4824
Dimensional International Core Equity Market ETF
DFAI
$18.2B
| $3.23M | ﹤0.01% |
+93,466
| New | +$3.06M |
|
|
EXAS
4825
DELISTED
Exact Sciences
EXAS
| $3.23M | ﹤0.01% |
60,766
-120,808
| -67% | -$6.14M |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.